Abbott Laboratories (BVMF:ABTT34)

Market Cap	1.01T -20.5%
Revenue (ttm)	244.16B +5.7%
Net Income	35.93B -51.3%
EPS	20.49 -51.3%
Shares Out	n/a
PE Ratio	27.99
Forward PE	19.41
Dividend	0.74 (1.54%)
Ex-Dividend Date	Jan 14, 2026

Volume	211
Average Volume	1,511
Open	47.85
Previous Close	47.65
Day's Range	47.77 - 48.08
52-Week Range	45.71 - 67.65
Beta	0.75
RSI	36.22
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 115,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ABTT34

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD